Logan Collins, based in United States, is currently a Co-Founder at Cathedral Therapeutics - acquired by General Cybernetics (successful exit). Logan Collins brings experience from previous roles at Cathedral Therapeutics, Foresight Institute AI Safety Grant Recipient for "Expansion X-ray Microscopy" P, Washington University in St. Louis and Independent. Logan Collins holds a 2020 - 2026 Doctor of Philosophy - PhD in Biomedical Engineering @ Washington University in St. Louis. Logan Collins has 2 emails and 1 mobile phone numbers on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.